{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T01:40:30Z","timestamp":1740706830793,"version":"3.38.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100005292","name":"Brigham and Women's Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005292","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.jneuroim.2025.578546","type":"journal-article","created":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T16:17:29Z","timestamp":1738945049000},"page":"578546","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Endocrine disrupting chemicals in early MS disease activity"],"prefix":"10.1016","volume":"400","author":[{"given":"Tzu-Ying","family":"Chuang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brenna A.","family":"LaBarre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osman","family":"Corbali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian C.","family":"Healy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shrishti","family":"Saxena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Talia B.","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eunnindy","family":"Sanon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taylor J.","family":"Saraceno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanuja","family":"Chitnis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jneuroim.2025.578546_bb0005","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1289\/ehp.0901560","article-title":"Urinary concentrations of four parabens in the U.S. population: NHANES 2005-2006","volume":"118","author":"Calafat","year":"2010","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.jneuroim.2025.578546_bb0010","series-title":"National Health and Nutrition Examination Survey Data","article-title":"National Center for Health Statistics (NCHS)","author":"Centers for Disease Control and Prevention (CDC)","year":"2024"},{"issue":"2","key":"10.1016\/j.jneuroim.2025.578546_bb0015","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.clim.2013.03.014","article-title":"Role of puberty in multiple sclerosis risk and course","volume":"149","author":"Chitnis","year":"2013","journal-title":"Clin. Immunol."},{"issue":"2","key":"10.1016\/j.jneuroim.2025.578546_bb0020","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1021\/es303640b","article-title":"Temporal variability in urinary phthalate metabolite excretion based on spot, morning, and 24-h urine samples: considerations for epidemiological studies","volume":"47","author":"Frederiksen","year":"2013","journal-title":"Environ. Sci. Technol."},{"issue":"11","key":"10.1016\/j.jneuroim.2025.578546_bb0025","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1001\/jamainternmed.2016.5766","article-title":"Endocrine-disrupting chemicals","volume":"176","author":"Gore","year":"2016","journal-title":"JAMA Intern. Med."},{"issue":"6","key":"10.1016\/j.jneuroim.2025.578546_bb0030","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1210\/er.2015-1010","article-title":"EDC-2: the Endocrine Society\u2019s second scientific statement on endocrine-disrupting chemicals","volume":"36","author":"Gore","year":"2015","journal-title":"Endocr. Rev."},{"issue":"2","key":"10.1016\/j.jneuroim.2025.578546_bb0035","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J. Biomed. Inform."},{"key":"10.1016\/j.jneuroim.2025.578546_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software platform partners","volume":"95","author":"Harris","year":"2019","journal-title":"J. Biomed. Inform."},{"issue":"3","key":"10.1016\/j.jneuroim.2025.578546_bb0045","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.repbio.2015.06.004","article-title":"Low-dose exposure to di-(2-ethylhexyl) phthalate (DEHP) increases susceptibility to testicular autoimmunity in mice","volume":"15","author":"Hirai","year":"2015","journal-title":"Reprod. Biol."},{"issue":"10","key":"10.1016\/j.jneuroim.2025.578546_bb0050","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1097\/JCMA.0000000000000802","article-title":"Serum parabens and its correlations with immunologic and cellular markers in southern Taiwan industrialized city systemic lupus erythematosus patients","volume":"85","author":"Huang","year":"2022","journal-title":"J. Chin. Med. Assoc."},{"issue":"3","key":"10.1016\/j.jneuroim.2025.578546_bb0055","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1289\/ehp.6663","article-title":"Mono(2-ethyl-5-hydroxyhexyl) phthalate and mono-(2-ethyl-5-oxohexyl) phthalate as biomarkers for human exposure assessment to di-(2-ethylhexyl) phthalate","volume":"112","author":"Kato","year":"2004","journal-title":"Environ. Health Perspect."},{"issue":"Suppl. 1","key":"10.1016\/j.jneuroim.2025.578546_bb0060","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/rcm.8258","article-title":"Mono(2-ethylhexyl) phthalate (MEHP) and mono(2-ethyl-5-oxohexyl) phthalate (MEOHP) but not di(2-ethylhexyl) phthalate (DEHP) bind productively to the peroxisome proliferator-activated receptor gamma","volume":"33","author":"Kratochvil","year":"2019","journal-title":"Rapid Commun. Mass Spectrom."},{"issue":"2","key":"10.1016\/j.jneuroim.2025.578546_bb0065","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1177\/1352458510384012","article-title":"Increasing incidence of multiple sclerosis in women in northern Finland","volume":"17","author":"Krokki","year":"2011","journal-title":"Mult. Scler."},{"issue":"24","key":"10.1016\/j.jneuroim.2025.578546_bb0070","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph17249403","article-title":"Adipose tissue and endocrine-disrupting chemicals: does sex matter?","volume":"17","author":"Le Magueresse-Battistoni","year":"2020","journal-title":"Int. J. Environ. Res. Public Health"},{"issue":"3","key":"10.1016\/j.jneuroim.2025.578546_bb0075","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1177\/1352458509358092","article-title":"Increasing female preponderance of multiple sclerosis in Isfahan, Iran: a population-based study","volume":"16","author":"Maghzi","year":"2010","journal-title":"Mult. Scler."},{"issue":"11","key":"10.1016\/j.jneuroim.2025.578546_bb0080","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/S1474-4422(06)70581-6","article-title":"Sex ratio of multiple sclerosis in Canada: a longitudinal study","volume":"5","author":"Orton","year":"2006","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jneuroim.2025.578546_bb0085","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.626107","article-title":"Interplay between endocrine disruptors and immunity: implications for diseases of autoreactive etiology","volume":"12","author":"Popescu","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"9","key":"10.1016\/j.jneuroim.2025.578546_bb0090","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1289\/ehp.02110917","article-title":"Combining xenoestrogens at levels below individual no-observed-effect concentrations dramatically enhances steroid hormone action","volume":"110","author":"Rajapakse","year":"2002","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.jneuroim.2025.578546_bb0095","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jocn.2016.12.030","article-title":"Gender ratio trends over time in multiple sclerosis patients from Argentina","volume":"38","author":"Rojas","year":"2017","journal-title":"J. Clin. Neurosci."},{"issue":"3","key":"10.1016\/j.jneuroim.2025.578546_bb0100","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1191\/135248506ms1267oa","article-title":"The relation between menarche and the age of first symptoms in a multiple sclerosis cohort","volume":"12","author":"Sloka","year":"2006","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jneuroim.2025.578546_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2020.110638","article-title":"Identifying windows of susceptibility to endocrine disrupting chemicals in relation to gestational weight gain among pregnant women attending a fertility clinic","volume":"194","author":"Tyagi","year":"2021","journal-title":"Environ. Res."},{"issue":"3","key":"10.1016\/j.jneuroim.2025.578546_bb0110","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1210\/er.2011-1050","article-title":"Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses","volume":"33","author":"Vandenberg","year":"2012","journal-title":"Endocr. Rev."},{"issue":"1","key":"10.1016\/j.jneuroim.2025.578546_bb0115","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1474-4422(15)00322-1","article-title":"Estriol combined with glatiramer acetate for women with relapsing-remitting multiple sclerosis: a randomised, placebo-controlled, phase 2 trial","volume":"15","author":"Voskuhl","year":"2016","journal-title":"Lancet Neurol."},{"issue":"Pt 6","key":"10.1016\/j.jneuroim.2025.578546_bb0120","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1093\/brain\/awh152","article-title":"Pregnancy and multiple sclerosis (the PRIMS study): clinical predictors of post-partum relapse","volume":"127","author":"Vukusic","year":"2004","journal-title":"Brain"},{"issue":"Pt 6","key":"10.1016\/j.jneuroim.2025.578546_bb0125","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1093\/brain\/aws099","article-title":"The Gulf war era multiple sclerosis cohort: age and incidence rates by race, sex and service","volume":"135","author":"Wallin","year":"2012","journal-title":"Brain"},{"issue":"14","key":"10.1016\/j.jneuroim.2025.578546_bb0130","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1177\/1352458520970841","article-title":"Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition","volume":"26","author":"Walton","year":"2020","journal-title":"Mult. Scler."},{"issue":"24","key":"10.1016\/j.jneuroim.2025.578546_bb0135","doi-asserted-by":"crossref","first-page":"6549","DOI":"10.1080\/10408398.2021.1903382","article-title":"Endocrine disrupting chemicals and breast cancer: a systematic review of epidemiological studies","volume":"62","author":"Wan","year":"2022","journal-title":"Crit. Rev. Food Sci. Nutr."},{"issue":"2","key":"10.1016\/j.jneuroim.2025.578546_bb0140","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ijheh.2014.11.001","article-title":"Associations between urinary phenol and paraben concentrations and markers of oxidative stress and inflammation among pregnant women in Puerto Rico","volume":"218","author":"Watkins","year":"2015","journal-title":"Int. J. Hyg. Environ. Health"},{"issue":"1","key":"10.1016\/j.jneuroim.2025.578546_bb0145","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1038\/s41598-022-06709-3","article-title":"Association between recurrent breast cancer and phthalate exposure modified by hormone receptors and body mass index","volume":"12","author":"Yang","year":"2022","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.jneuroim.2025.578546_bb0150","doi-asserted-by":"crossref","first-page":"4097","DOI":"10.1210\/en.2012-1422","article-title":"Endocrine-disrupting chemicals and public health protection: a statement of principles from the Endocrine Society","volume":"153","author":"Zoeller","year":"2012","journal-title":"Endocrinology"}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572825000268?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572825000268?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T01:20:23Z","timestamp":1740705623000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572825000268"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":30,"alternative-id":["S0165572825000268"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2025.578546","relation":{},"ISSN":["0165-5728"],"issn-type":[{"type":"print","value":"0165-5728"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endocrine disrupting chemicals in early MS disease activity","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2025.578546","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"578546"}}